Analysis of Human RSV Immunity at the Molecular Level: Learning from the Past and Present
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Analysis of Human RSV Immunity at the Molecular Level: Learning from the Past and Present
Authors
Keywords
T cells, Antibodies, Antibody response, Enzyme-linked immunoassays, Protein structure, Vaccines, Antigens, B cells
Journal
PLoS One
Volume 10, Issue 5, Pages e0127108
Publisher
Public Library of Science (PLoS)
Online
2015-05-23
DOI
10.1371/journal.pone.0127108
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The CD4 T cell response to respiratory syncytial virus infection
- (2014) Allison F. Christiaansen et al. IMMUNOLOGIC RESEARCH
- Proof of principle for epitope-focused vaccine design
- (2014) Bruno E. Correia et al. NATURE
- Development of Safe and Effective RSV Vaccine by Modified CD4 Epitope in G Protein Core Fragment (Gcf)
- (2014) In Su Cheon et al. PLoS One
- Cross-neutralization of four paramyxoviruses by a human monoclonal antibody
- (2013) Davide Corti et al. NATURE
- Structure-Based Design of a Fusion Glycoprotein Vaccine for Respiratory Syncytial Virus
- (2013) J. S. McLellan et al. SCIENCE
- The path to an RSV vaccine
- (2013) Christine A Shaw et al. Current Opinion in Virology
- Protective and dysregulated T cell immunity in RSV infection
- (2013) Peter J Openshaw et al. Current Opinion in Virology
- A Meta-Analysis of the Existing Knowledge of Immunoreactivity against Hepatitis C Virus (HCV)
- (2012) Yohan Kim et al. PLoS One
- Neutralizing antibodies against the preactive form of respiratory syncytial virus fusion protein offer unique possibilities for clinical intervention
- (2012) M. Magro et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Reliable B Cell Epitope Predictions: Impacts of Method Development and Improved Benchmarking
- (2012) Jens Vindahl Kringelum et al. PLoS Computational Biology
- Analysis of Respiratory Syncytial Virus Preclinical and Clinical Variants Resistant to Neutralization by Monoclonal Antibodies Palivizumab and/or Motavizumab
- (2011) Qing Zhu et al. JOURNAL OF INFECTIOUS DISEASES
- Structure of Respiratory Syncytial Virus Fusion Glycoprotein in the Postfusion Conformation Reveals Preservation of Neutralizing Epitopes
- (2011) J. S. McLellan et al. JOURNAL OF VIROLOGY
- Structural basis for immunization with postfusion respiratory syncytial virus fusion F glycoprotein (RSV F) to elicit high neutralizing antibody titers
- (2011) K. A. Swanson et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Prospects for defined epitope vaccines for respiratory syncytial virus
- (2010) Robert Anderson et al. Future Microbiology
- Structure of a Major Antigenic Site on the Respiratory Syncytial Virus Fusion Glycoprotein in Complex with Neutralizing Antibody 101F
- (2010) J. S. McLellan et al. JOURNAL OF VIROLOGY
- A large-scale protein-function database
- (2010) Rolf Apweiler et al. Nature Chemical Biology
- Generation of stable monoclonal antibody–producing B cell receptor–positive human memory B cells by genetic programming
- (2009) Mark J Kwakkenbos et al. NATURE MEDICINE
- ElliPro: a new structure-based tool for the prediction of antibody epitopes
- (2008) Julia Ponomarenko et al. BMC BIOINFORMATICS
- Host immunity during RSV pathogenesis
- (2008) Susan M. Bueno et al. INTERNATIONAL IMMUNOPHARMACOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now